Company intelligence / Profile preview

Medicis Pharmaceutical

Bridgewater, New Jersey, United Statesmedi.ci ↗

Ownership: Private
Employees: ~700
Development stage: Other

Overview

Medicis was a leading specialty pharmaceutical company focused on dermatology and aesthetic medicine. Its portfolio included several market-leading brands for acne treatment and cosmetic dermatology. The company was acquired by Valeant Pharmaceuticals in 2012 for $2.6 billion. At the time of acquisition it had multiple commercial products and some mid-to-late stage pipeline assets.

Therapeutic areas: Dermatology
Modalities: Small moleculeBiologicDevice
Industry: Biotech

Partnerships

Notable product licensing/acquisition deals with SmithKline Beecham

Beyond the preview

Go deeper on Medicis Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicis Pharmaceutical.

Explore the full profile